Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01688388 · ClinicalTrials.gov registry record · NA
Single Fraction Intraoperative Radiotherapy
A NA study of Stage II Breast Carcinoma and Stage 0 Breast Carcinoma, sponsored by St. Joseph Hospital of Orange.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT01688388 is a NA study of Stage II Breast Carcinoma and Stage 0 Breast Carcinoma that has completed, run by St. Joseph Hospital of Orange. The registered enrollment target is 250 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01688388, a NA study of Stage II Breast Carcinoma and Stage 0 Breast Carcinoma, has completed, sponsored by St. Joseph Hospital of Orange.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial is being conducted to find out the effects (good and bad) of giving the full radiation treatment for breast cancer as a single dose of radiation during surgery for breast cancer. This single fraction intraoperative radiotherapy with electrons will study the toxicity, local control and cosmetic outcome.
Conditions Studied
Interventions
- PROCEDURE Intraoperative Radiotherapy
Study Locations (1)
California
- St. Joseph Hospital of Orange - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2012-02 |
| Est. Completion | 2022-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01688388
The ClinicalTrials.gov registry entry for NCT01688388 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Joseph Hospital of Orange, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Stage II Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Intraoperative Radiotherapy is the first listed.
NCT01688388 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01688388 about?
NCT01688388 is a clinical study titled "Single Fraction Intraoperative Radiotherapy". This clinical trial is being conducted to find out the effects (good and bad) of giving the full radiation treatment for breast cancer as a single dose of radiation during surgery for breast cancer. This single fraction intraoperative radiotherapy with electrons will study the toxicity, local contro...
What is the current status of trial NCT01688388?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2012-02. Estimated completion is 2022-02.
What conditions does trial NCT01688388 study?
This clinical trial studies the following conditions: Stage II Breast Carcinoma, Stage 0 Breast Carcinoma, Stage I Breast Carcinoma, Invasive Ductal and Invasive Lobular Breast Carcinoma.
What interventions are being tested in trial NCT01688388?
The interventions under investigation include: Intraoperative Radiotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT01688388?
This trial is sponsored by St. Joseph Hospital of Orange, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01688388 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage II Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.